Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Alternative tests with better results and less use of animals

25.10.2004


There is a patent demand in the pharmaceutical, cosmetic and chemical industry for new alternative testing in order to assess the acute toxicity of new drugs, cosmetic ingredients or industrial chemical products that have to be in contact with humans or the natural environment.



The aim is to reduce the time for and cost of studies for the development of new active elements and reduce the number of experimental animals. Equally, these tests enable direct work on human cell lines instead of on animals, in order to study the toxicity of the liver or kidney, amongst other organs.

To this end, the validation of this new in vitro work methodology, compared to the conventional in vivo one is urgently needed, not only by corporate industry but also by the European Directives themselves. Both REACH (the UE regulating body for chemical products) and the 7th amendment to the Directive on cosmetics propose the replacement in, the short term, of animal experimentation. Currently, while a number of animal testing procedures for toxicity have been successfully substituted by alternative methods, systemic toxicities require new strategic tests to reach a suitable level of safety for the consumer.


In this context, and thanks to its potential in terms of infrastructure as well as qualified and experienced personnel (BPL certificates -10.BPLI/98.01/001 MSC-), in August 2003 GAIKER became part of A-Cute-Tox, a platform financed by the UE and made up of 37 companies and research centres (Integrated Project) drawn from 13 European countries. Its aim is to develop a simple and robust in vitro testing strategy for the prediction of acute human systemic toxicity, which can substitute the tests for acute animal toxicity currently used as regulators.

This approach requires the dimensions of a transnational integrated project, and the involvement of prominent toxicity research groups in the European Union, strict supervision and the introduction of the regulating community and professional handling. It offers the real possibility of getting a substantial reduction of experiments with acute animal systemic toxicity. The involvement of the European Centre for Validation of Alternative Methods (ECVAM) in the management of the project and the other regulatory bodies, such as the ECB (European Chemicals Bureau), guarantees control of the final goal of the project.

Jose Maria Goenaga | Basque research
Further information:
http://www.gaiker.es

More articles from Life Sciences:

nachricht Scientists unveil completely human platform for testing age-specific vaccine responses
20.11.2018 | Boston Children's Hospital

nachricht From Receptor Structure to New Osteoporosis Drugs
20.11.2018 | Universität Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Optical Coherence Tomography: German-Japanese Research Alliance hosted Medical Imaging Conference

19.11.2018 | Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

 
Latest News

When AI and optoelectronics meet: Researchers take control of light properties

20.11.2018 | Physics and Astronomy

Researchers use MRI to predict Alzheimer's disease

20.11.2018 | Medical Engineering

How to melt gold at room temperature

20.11.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>